"bms" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonFDA grants breakthrough therapy status to SystImmune, BMS lung cancer drug - Investing.com
FDA grants breakthrough therapy status to SystImmune, BMS lung cancer drug Investing.com
Privacy Notice Center - Bristol Myers Squibb
Privacy Notice Center Bristol Myers Squibb
Smart Bms KACOME BMS 24V 48V 8S/16S 100A 150A 200A LiFePo4 Li 16s Bms - roarmag.org
Smart Bms KACOME BMS 24V 48V 8S/16S 100A 150A 200A LiFePo4 Li 16s Bms roarmag.org
The Bristol Myers Squibb Foundation - Bristol Myers Squibb
The Bristol Myers Squibb Foundation Bristol Myers Squibb
Global Patient Week 2024 - Bristol Myers Squibb
Global Patient Week 2024 Bristol Myers Squibb
Independent research - Bristol Myers Squibb
Independent research Bristol Myers Squibb
Doctorx Unscripted Bold Conversations about Patient-Driven Science - Bristol Myers Squibb
Doctorx Unscripted Bold Conversations about Patient-Driven Science Bristol Myers Squibb
BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding - Fierce Biotech
BMS hands 5 autoimmune drugs to new spinout backed by $300M in Bain-led funding Fierce Biotech
Worldwide locations - Bristol Myers Squibb
Worldwide locations Bristol Myers Squibb
Become a business supplier - Bristol Myers Squibb
Become a business supplier Bristol Myers Squibb
Global Inclusion & Diversity - Bristol Myers Squibb
Global Inclusion & Diversity Bristol Myers Squibb
Chris Shibutani, MD - Bristol Myers Squibb
Chris Shibutani, MD Bristol Myers Squibb
Areas of interest - Bristol Myers Squibb
Areas of interest Bristol Myers Squibb
Layoff Tracker: Bausch Health Closes California Site, Cuts 49 Employees - BioSpace
Layoff Tracker: Bausch Health Closes California Site, Cuts 49 Employees BioSpace
About us - Bristol Myers Squibb
About us Bristol Myers Squibb
Encouraging the next generation to pursue STEM education - Bristol Myers Squibb
Encouraging the next generation to pursue STEM education Bristol Myers Squibb
People and business resource groups - Bristol Myers Squibb
People and business resource groups Bristol Myers Squibb
Our research in neuroscience - Bristol Myers Squibb
Our research in neuroscience Bristol Myers Squibb
Our research in immunology - Bristol Myers Squibb
Our research in immunology Bristol Myers Squibb
Bristol Myers touts commercial execution, reckons with recent clinical setbacks - Fierce Pharma
Bristol Myers touts commercial execution, reckons with recent clinical setbacks Fierce Pharma
Psoriasis around the world - Bristol Myers Squibb
Psoriasis around the world Bristol Myers Squibb
Bristol-Myers Squibb’s Promising Study on BMS-986470 for Sickle Cell Disease: A Financial Perspec...
War 2 VS Coolie Day 4 BMS Sales: Rajinikanth Takes 65% Lead Over Hrithik Roshan – Jr NTR’s Biggie...
Future of BMS’ Cobenfy Still in Limbo After Phase III Fail - BioSpace
Future of BMS’ Cobenfy Still in Limbo After Phase III Fail BioSpace
Featured Researcher: Roland Chen - Bristol Myers Squibb
Featured Researcher: Roland Chen Bristol Myers Squibb
Clinical trials & studies - Bristol Myers Squibb
Clinical trials & studies Bristol Myers Squibb
Transparency & reporting - Bristol Myers Squibb
Transparency & reporting Bristol Myers Squibb
Business development leadership team - Bristol Myers Squibb
Business development leadership team Bristol Myers Squibb
BMS, Bain Capital team up on autoimmune-focused newco - FirstWord Pharma
BMS, Bain Capital team up on autoimmune-focused newco FirstWord Pharma
Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abb...
Post study drug access to BMS investigational medicinal products and approved products - Bristol ...
Post study drug access to BMS investigational medicinal products and approved products Bristol Myers Squibb
Exclusive: Howden's North American commercial property director Jordan heads to BMS - The Insurer
Exclusive: Howden's North American commercial property director Jordan heads to BMS The Insurer
Research and development center Cambridge, Massachusetts - Bristol Myers Squibb
Research and development center Cambridge, Massachusetts Bristol Myers Squibb
Our impact - Bristol Myers Squibb
Our impact Bristol Myers Squibb
BMS names AstraZeneca's Cristian Massacesi as new chief medical officer - Fierce Biotech
BMS names AstraZeneca's Cristian Massacesi as new chief medical officer Fierce Biotech
Michael R. McMullen - Bristol Myers Squibb
Michael R. McMullen Bristol Myers Squibb
Annual reports - Bristol Myers Squibb
Annual reports Bristol Myers Squibb
Pre-approval access to investigational medicines - Bristol Myers Squibb
Pre-approval access to investigational medicines Bristol Myers Squibb
Science Firsthand: Predicting new possibilities in drug discovery - Bristol Myers Squibb
Science Firsthand: Predicting new possibilities in drug discovery Bristol Myers Squibb
2025 Annual Meeting of Shareholders - Bristol Myers Squibb
2025 Annual Meeting of Shareholders Bristol Myers Squibb
Looking to the Future of Cell Therapy - Bristol Myers Squibb
Looking to the Future of Cell Therapy Bristol Myers Squibb
Expanding access to lung cancer screening - Bristol Myers Squibb
Expanding access to lung cancer screening Bristol Myers Squibb
Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion - Fi...
Bristol Myers braves failed Reblozyl phase 3, plans FDA talks for potential anemia expansion Fierce Pharma
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis - Fierce Pharma
BMS, RayzeBio launch radiopharmaceutical manufacturing site in Indianapolis Fierce Pharma
Science Firsthand: The pathway to drug discovery - Bristol Myers Squibb
Science Firsthand: The pathway to drug discovery Bristol Myers Squibb
A global journey through BMS’ R&D hubs - Bristol Myers Squibb
A global journey through BMS’ R&D hubs Bristol Myers Squibb
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO FirstWord Pharma
Braemar (LON:BMS) Shares Pass Above 200 Day Moving Average - Time to Sell? - MarketBeat
Braemar (LON:BMS) Shares Pass Above 200 Day Moving Average - Time to Sell? MarketBeat
Why partner with us - Bristol Myers Squibb
Why partner with us Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
Women innovators in AI transforming patient care - Bristol Myers Squibb
Women innovators in AI transforming patient care Bristol Myers Squibb
Immunology patient resources - Bristol Myers Squibb
Immunology patient resources Bristol Myers Squibb
BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900 - BioSpace
BMS Continues New Jersey Layoffs, Bringing Yearly Total to Nearly 900 BioSpace
How BMS employees champion STEM education & diversity - Bristol Myers Squibb
How BMS employees champion STEM education & diversity Bristol Myers Squibb
Go green network - Bristol Myers Squibb
Go green network Bristol Myers Squibb
Protein homeostasis 101: A Q&A with Mark Rolfe - Bristol Myers Squibb
Protein homeostasis 101: A Q&A with Mark Rolfe Bristol Myers Squibb
Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb
Science Firsthand: Translating the promise of cell therapy Bristol Myers Squibb
Open Source Lithium-Titanate Battery Management System - Hackaday
Open Source Lithium-Titanate Battery Management System Hackaday
BMS to close Illinois site as part of cell therapy manufacturing consolidation - FirstWord Pharma
BMS to close Illinois site as part of cell therapy manufacturing consolidation FirstWord Pharma
Our science - Bristol Myers Squibb
Our science Bristol Myers Squibb
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel ...
BMS-986365: Targeting AR Degradation and Antagonism in Metastatic Prostate Cancer - Manish Patel UroToday
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C...
300+ employees from 33 nations will cycle to advance cancer research, celebrating 12 years of C2C4C Bristol Myers Squibb
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC - Fierce Biotech
Biokin, having landed BMS deal, posts ph. 3 cancer win for bispecific ADC Fierce Biotech
BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration - Genetic Engineering and B...
BMS, BioNTech Ink Up-to-$11B Cancer Bispecific Antibody Collaboration Genetic Engineering and Biotechnology News
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs - Bristol Myers Squibb
RayzeBio’s new hub revolutionizes cancer treatment with next-gen RPTs Bristol Myers Squibb
Derica W. Rice - Bristol Myers Squibb
Derica W. Rice Bristol Myers Squibb
Chris Boerner, PhD - Bristol Myers Squibb
Chris Boerner, PhD Bristol Myers Squibb
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal - Fierce Biotech
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal Fierce Biotech
BMS outlays $11bn to join BioNTech’s development of bispecific cancer drug - Pharmaceutical Techn...
BMS outlays $11bn to join BioNTech’s development of bispecific cancer drug Pharmaceutical Technology
Bristol-Myers Squibb’s New Study on NSCLC Treatment: Market Implications - TipRanks
Bristol-Myers Squibb’s New Study on NSCLC Treatment: Market Implications TipRanks
BMS Commits $40B over Five Years to U.S. R&D, Manufacturing - Genetic Engineering and Biotechnolo...
BMS Commits $40B over Five Years to U.S. R&D, Manufacturing Genetic Engineering and Biotechnology News
BMS growth driver Camzyos fails in heart disease trial, denting expansion opportunity - Fierce Ph...
BMS growth driver Camzyos fails in heart disease trial, denting expansion opportunity Fierce Pharma
Building a better future: Bristol Myers Squibb 2023 ESG report - Bristol Myers Squibb
Building a better future: Bristol Myers Squibb 2023 ESG report Bristol Myers Squibb
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst ...
Déjà vu for Bristol Myers as it faces another anti-competition lawsuit over blockbuster Pomalyst Fierce Pharma
Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pf...
Bristol Myers inks $11B BioNTech deal to join bispecific gold rush, leaping ahead of Merck and Pfizer Fierce Biotech
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief...
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer Bristol Myers Squibb
Wendy Short Bartie - Bristol Myers Squibb
Wendy Short Bartie Bristol Myers Squibb
Predict First: BMS Executives Discuss Company’s AI Approach - Genetic Engineering and Biotechnolo...
Predict First: BMS Executives Discuss Company’s AI Approach Genetic Engineering and Biotechnology News
BMS scales back at former Novartis plant, shifting cell therapy vector production to MA - Fierce ...
BMS scales back at former Novartis plant, shifting cell therapy vector production to MA Fierce Pharma
Pioneering Innovative Drug Development at Cambridge Crossing Facility - Bristol Myers Squibb
Pioneering Innovative Drug Development at Cambridge Crossing Facility Bristol Myers Squibb
'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US...
'Now is not the time to retreat': BMS CEO blasts Trump admin tariffs, health reforms amid $40B US investment pledge Fierce Pharma
Six BMS employees will participate in the 10th edition of the C2C4C cycle race - Bristol Myers Sq...
Six BMS employees will participate in the 10th edition of the C2C4C cycle race Bristol Myers Squibb
Advancing myeloma care: Taking action for the community - Bristol Myers Squibb
Advancing myeloma care: Taking action for the community Bristol Myers Squibb
Tesla Model 3 hits quarter million miles with original battery and motor - Teslarati
Tesla Model 3 hits quarter million miles with original battery and motor Teslarati
Shaping a new era in cancer research - Bristol Myers Squibb
Shaping a new era in cancer research Bristol Myers Squibb
Over 500 BMS jobs axed in latest round of NJ cuts - FirstWord Pharma
Over 500 BMS jobs axed in latest round of NJ cuts FirstWord Pharma
BMS taps biotech analyst from Goldman Sachs to lead long-term strategy - Fierce Biotech
BMS taps biotech analyst from Goldman Sachs to lead long-term strategy Fierce Biotech
Deepak L. Bhatt, MD, MPH, MBA - Bristol Myers Squibb
Deepak L. Bhatt, MD, MPH, MBA Bristol Myers Squibb
Reaching more patients with cell therapy fact sheet - Bristol Myers Squibb
Reaching more patients with cell therapy fact sheet Bristol Myers Squibb
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem - BioSpace
BMS Expands Radiopharma Presence With $1.35B Biobucks Deal for Philochem BioSpace
Bristol Myers, Bain Capital form new company to develop immunology drugs - Reuters
Bristol Myers, Bain Capital form new company to develop immunology drugs Reuters
Cathi Ahearn - Bristol Myers Squibb
Cathi Ahearn Bristol Myers Squibb
Leveraging AI to enhance workplace innovation & efficiency - Bristol Myers Squibb
Leveraging AI to enhance workplace innovation & efficiency Bristol Myers Squibb
U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Inj...
Paula A. Price - Bristol Myers Squibb
Paula A. Price Bristol Myers Squibb
Leading innovation in cardiovascular disease - Bristol Myers Squibb
Leading innovation in cardiovascular disease Bristol Myers Squibb
Making Advances in Cancer Research Development - Bristol Myers Squibb
Making Advances in Cancer Research Development Bristol Myers Squibb
BMS's Camzyos falls short in Phase III non-obstructive HCM trial - FirstWord Pharma
BMS's Camzyos falls short in Phase III non-obstructive HCM trial FirstWord Pharma
Coolie Box Office Day 5: Huge Monday Drop Incoming As Rajinikanth Registers Only 30% Of Amaran’s ...
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans - BioSpace
BMS Pledges $40B Investment in US Despite Cost-Cutting Plans BioSpace